ASRT vs HCA · rev $125.0M vs P/E 17, rev $75.60B
Assertio Therapeutics Inc (ASRT) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
ASRT currently screens at market cap $151.5M. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the ASRT and HCA stock pages for the full models.
Not investment advice.